Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Cook

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
American Journal of Therapeutics|July 17, 2010
Implantable cardioverter-defibrillators in patients hospitalized for heart failure with chronically reduced left ventricular ejection fractionNorman C Wang, Jonathan P Piccini, Marvin A Konstam, et al.
Journal of the American College of Cardiology|November 11, 2008
Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) programJohn E A Blair, Faiez Zannad, Marvin A Konstam, et al.
JAMA|June 12, 2008
Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fractionNorman C Wang, Aldo P Maggioni, Marvin A Konstam, et al.
European Heart Journal|January 8, 2013
Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trialAndrew P Ambrosy, Peter S Pang, Sadiya Khan, et al.
European Heart Journal|July 26, 2011
Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trialJohn E A Blair, Peter S Pang, Robert W Schrier, et al.
International Journal of Biological Macromolecules|June 23, 2023
Boosting the photodynamic activity of erythrosine B by using thermoresponsive and adhesive systems containing cellulose derivatives for topical deliveryJéssica Bassi da Silva, Rafaela Said Dos Santos, Camila Felix Vecchi, et al.
American Heart Journal|May 4, 2010
Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) programChristopher M O'Connor, Alan B Miller, John E A Blair, et al.
Molecular Neurobiology|January 11, 2020
Ancestral Folate Promotes Neuronal Regeneration in Serial Generations of ProgenyNirav J Patel, Kirk J Hogan, Elias Rizk, et al.
Molecular Neurobiology|February 1, 2020
Correction to: Ancestral Folate Promotes Neuronal Regeneration in Serial Generations of ProgenyNirav J Patel, Kirk J Hogan, Elias Rizk, et al.
Urology|April 3, 2003
Long-term 6-year experience with finasteride in patients with benign prostatic hyperplasiaFranklin C Lowe, John D McConnell, Perry B Hudson, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
American Journal of Therapeutics|July 17, 2010
Implantable cardioverter-defibrillators in patients hospitalized for heart failure with chronically reduced left ventricular ejection fractionNorman C Wang, Jonathan P Piccini, Marvin A Konstam, et al.
Journal of the American College of Cardiology|November 11, 2008
Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) programJohn E A Blair, Faiez Zannad, Marvin A Konstam, et al.
JAMA|June 12, 2008
Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fractionNorman C Wang, Aldo P Maggioni, Marvin A Konstam, et al.
European Heart Journal|January 8, 2013
Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trialAndrew P Ambrosy, Peter S Pang, Sadiya Khan, et al.
European Heart Journal|July 26, 2011
Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trialJohn E A Blair, Peter S Pang, Robert W Schrier, et al.
International Journal of Biological Macromolecules|June 23, 2023
Boosting the photodynamic activity of erythrosine B by using thermoresponsive and adhesive systems containing cellulose derivatives for topical deliveryJéssica Bassi da Silva, Rafaela Said Dos Santos, Camila Felix Vecchi, et al.
American Heart Journal|May 4, 2010
Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) programChristopher M O'Connor, Alan B Miller, John E A Blair, et al.
Molecular Neurobiology|January 11, 2020
Ancestral Folate Promotes Neuronal Regeneration in Serial Generations of ProgenyNirav J Patel, Kirk J Hogan, Elias Rizk, et al.
Molecular Neurobiology|February 1, 2020
Correction to: Ancestral Folate Promotes Neuronal Regeneration in Serial Generations of ProgenyNirav J Patel, Kirk J Hogan, Elias Rizk, et al.
Urology|April 3, 2003
Long-term 6-year experience with finasteride in patients with benign prostatic hyperplasiaFranklin C Lowe, John D McConnell, Perry B Hudson, et al.
Pageof 7